By agreeing to these terms you indicate you are employed by one of the RegMed XB signatory partners. As such you are bound by strict confidentiality as described in the consortium agreement.
This portal and all of its information and documents are confidential and/or proprietary information and is intended for RegMed XB consortium partners only. Any unauthorized use of the information contained herein (including, but not limited to, alteration, reproduction, communication, distribution or any other form of dissemination) is strictly prohibited. If you are not the employed by a RegMed XB consortium partner, please notify the RegMed XB office (This email address is being protected from spambots. You need JavaScript enabled to view it.) promptly and delete all obtained information/documents subsequently.
Please refer to the RegMed XB Phase 1 consortium agreement for the full Terms & Conditions
RegMed XB Consortium partners:
300MICRONS Access2bone Chemelot InSciTe CytoSMART Diabetesfonds Nederland TU Eindhoven Foundation RegMed XB Fujifilm Manufacturing Galapagos Hartstichting HCM-Medical Innophysics
KU Leuven Kuros Leiden UMC Leiden Regenerative Medicine Platform (LRMP) Nierstichting LifeTec Group Maastricht University Materiomics Mimetas Ncardia Nestegg
NTrans Osteo-Pharma ReumaNederland STENTiT Stichting DON Suprapolix UMC Utrecht Utrecht University Veldlaser Visualsonics Xeltis Other (event registration only)
